Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2005
06/16/2005CA2547248A1 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
06/16/2005CA2545422A1 Tubulin inhibitors
06/15/2005EP1541562A1 Novel uracil derivatives and medicinal use thereof
06/15/2005EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
06/15/2005EP1540012A2 Polymorphisms for predicting disease and treatment outcome
06/15/2005EP1539760A2 Azapurine derivatives
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539712A1 Pyrimidine derivatives and their use as cb2 modulators
06/15/2005EP1539711A1 Process for preparing the calcium salt of rosuvastatin
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539705A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1450808B1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/15/2005EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/15/2005EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1095027B1 Substituted phenyl uracils
06/15/2005CN1628104A Quinazolinone derivatives and their use as CB agonists
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626532A Amide compounds
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/14/2005US6906079 Method and reagents for N-alkylating ureides
06/14/2005US6906076 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides
06/14/2005US6906068 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6905455 Radioactive member and method of making
06/14/2005CA2101684C Substituted (hetero)aryl compounds, process for their preparation, agents containing them, and their use as safeners
06/09/2005WO2005053055A1 Organic electroluminescent element
06/09/2005WO2005051974A2 Novel molecules for regulating cell death
06/09/2005WO2005051951A1 A2b adenosine receptor antagonists
06/09/2005WO2005051925A1 Crystal of phenylalanine derivative and process for producing the same
06/09/2005WO2005051924A1 Quinazoline derivative and process for producing the same
06/09/2005WO2005051923A1 Quinazoline derivatives
06/09/2005WO2005051922A1 Quinazolinone compounds as anticancer agents
06/09/2005WO2005051921A1 Crystalline ammonium salts of rosuvastatin
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005WO2005051366A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051300A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
06/09/2005WO2005013903A3 Derivatives of substituted quinone and uses thereof
06/09/2005WO2005007092A3 Novel chemical compounds
06/09/2005US20050124810 Purity; hydrate forms
06/09/2005US20050124809 Process for producing quinazolin-4-one and derivatives thereof
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta
06/09/2005US20050124639 Improved process for the preparation of pyrimidine derivatives such as 3-hydroxy-3-methylglutaryl-coenzyme A inhibitors and their intermediates, specifically, for the preparation of rosuvastatin and its intermediates using Wittig reagents
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/09/2005US20050124600 And thiones, 1-substituted with a (hetero)aryl)carbonyl group, e.g., 6-Bromo-1-[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]-8-methyl-3-(1-methylethyl)-2,4(1H,3R)-quinazolinedione; especially for use in growing and stored agronomic crops
06/09/2005US20050124562 Using Dna polymerase inhibitor as bactericide
06/09/2005US20050124561 Administering fungicide for mucous membrane; asthma therapy
06/09/2005US20050124498 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123597 Releasable linkage and compositions containing same
06/09/2005CA2547284A1 Quinazoline derivative and process for producing the same
06/09/2005CA2546932A1 Quinazolinone compounds as anticancer agents
06/09/2005CA2546733A1 A2b adenosine receptor antagonists
06/09/2005CA2546673A1 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
06/09/2005CA2546486A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2546353A1 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545660A1 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005CA2545659A1 Bicyclic inhibitors of mek
06/09/2005CA2545601A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005CA2545262A1 Quinazoline derivatives
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1538138A1 Substituted benzanilide compound and pest control agent
06/08/2005EP1537111A1 Hetereoaryl nitrile derivatives
06/08/2005EP1537089A2 Compounds compositions and methods
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1537072A1 Substituted aminoethers for the treatment of alzheimer s disease
06/08/2005EP1537068A1 Materials and methods for treating hypercholesterolemia
06/08/2005EP1536799A1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds
06/08/2005EP1057816B1 Method for producing heteroaromatic aldehydes
06/08/2005CN1625401A Non-sedating barbituric acid derivatives
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1623988A Biaryl sulfonamides and methods for using same
06/08/2005CN1205192C Acylated amino-benzenesulfonyl urea, its prepn .and as herbicide and plant-growth regulator
06/08/2005CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
06/08/2005CN1205189C Polyhaloalkyl ether derivatives and liquid crystal compositions and liquid crystal display elements containing them
06/07/2005US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/07/2005US6903213 HIV inhibiting pyrimidine derivatives
06/07/2005US6903107 Serine protease inhibitor
06/07/2005US6903106 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6902663 Adding to ethylenically unsaturated monomers, an effective amount of C-nitrosoaniline compounds to inhibit premature polymerization of monomers
06/07/2005US6901929 Aerosolization; comprises pressurization cylinders; drug delivery
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2068790C Antiviral compounds
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 427